Skip to main content
. 2023 Feb 16;25(4):1229–1237. doi: 10.1177/11297298231154629

Table 2.

Intravenous access data for cohort groups.

Non-CG group n = 4457 (%) CG group n = 3873 (%) p-Value
Catheter size (Ga.)
 24. 50 (1) 4 (1) <0.001
 26 4407 (99) 3869 (99)
Indication
 Blood products 160 (4) 170 (4) <0.001
 Continuous infusion 3980 (89) 3203 (83)
 Intermittent infusion 250 (6) 429 (11)
 Procedure* 67 (1) 71 (2)
Side of cannulation
 Left 2417 (54) 2204 (57) 0.014
 Right 2040 (46) 1669 (43)
Site of cannulation
 Elbow 3 (<1) 0 (0) <0.001
 Foot 630 (14) 331 (8)
 Hand 3656 (82) 3430 (89)
 Lower arm 157 (3) 105 (3)
 Lower leg 5 (<1) 4 (<1)
 Upper arm 4 (<1) 1 (<1)
 Upper leg 2 (<1) 2 (<1)
Attempts Skin punctures 1.3 ± 0.5 1.4 ± 0.7
Reason of removal
 Elective 1655 (37) 1919 (49) <0.001
 Accidental 130 (3) 105 (3)
 Leaking 445 (10) 386 (10)
 Occlusion 219 (5) 160 (4)
 Phlebitis 594 (13) 123 (3)
 Infiltration/extravasation 1365 (31) 1121 (29)
 Lost to follow-up 49 (1) 59 (2)
Dwell time
 Hours 31.0 ± 24.3 37.1 ± 31.1 <0.001

Ga.: gage; PIVIE: peripheral intravenous infiltration/extravasation.

Data are represented as mean ± standard deviation, or as absolute numbers (percentages rounded to the nearest full number where appropriate). Data is tested with χ2 testing or with unpaired t-testing, as appropriate.

*

VAD insertion related to a procedure if required in diagnostic imaging like MRI or CT-scan.